AtriCure
ATRC • NASDAQ
AtriCure is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Michael H. Carrel, with a market cap of $1.4B.
CEOMichael H. Carrel
Next Earnings
Upcoming earnings announcement for AtriCure
Date
Tuesday, April 28, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.06
Revenue Estimate
$139.4M
Earnings History
Past 12 earnings reports for AtriCure
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | $0.06Est: -$0.04 | +250.0% | $140.5MEst: $140.1M | +0.3% |  10-K |
| Oct 29, 2025 | Q3 2025 | -$0.01Est: -$0.11 | +90.9% | $134.3MEst: $131.4M | +2.2% | 10-Q |
| Jul 29, 2025 | Q2 2025 | -$0.02Est: -$0.16 | +87.5% | $136.1MEst: $130.2M | +4.6% | 10-Q |
| Apr 29, 2025 | Q1 2025 | -$0.14Est: -$0.22 | +36.4% | $123.6MEst: $122.9M | +0.6% | 10-Q |
| Feb 12, 2025 | Q4 2024 | -$0.08Est: -$0.15 | +46.7% | $124.3MEst: $121.8M | +2.0% | 10-K |
| Oct 29, 2024 | Q3 2024 | -$0.17Est: -$0.19 | +10.5% | $115.9MEst: $112.3M | +3.3% | 10-Q |
| Jul 30, 2024 | Q2 2024 | -$0.17Est: -$0.17 | 0.0% | $116.3MEst: $116.2M | +0.1% | 10-Q |
| May 1, 2024 | Q1 2024 | -$0.25Est: -$0.23 | -8.7% | $108.9MEst: $106.9M | +1.8% | 10-Q |
| Feb 15, 2024 | Q4 2023 | -$0.21Est: -$0.23 | +8.7% | $106.5MEst: $103.7M | +2.8% | 10-K |
| Nov 1, 2023 | Q3 2023 | -$0.20Est: -$0.31 | +35.5% | $98.3MEst: $96.7M | +1.6% | — |
| Jul 25, 2023 | Q2 2023 | -$0.12Est: -$0.29 | +58.6% | $100.9MEst: $97.5M | +3.5% | 10-Q |
| May 2, 2023 | Q1 2023 | -$0.23Est: -$0.34 | +32.4% | $93.5MEst: $87.5M | +6.8% | — |